| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.884 | 0.004 | 0.904 | Caspase 9 stimulant | 0.904 0.003 CHEMBL210635 0.656 0.029 CHEMBL3526944 0.554 0.044 CHEMBL3526945 | CHEMBL210635 | |
| 0.789 | 0.005 | 0.825 | Aryl hydrocarbon receptor agonist | 0.825 0.005 CHEMBL210635 0.189 0.108 CHEMBL3526944 0.168 0.122 CHEMBL3526945 | CHEMBL210635 | |
| 0.778 | 0.005 | 0.936 | Aldehyde oxidase inhibitor | 0.936 0.003 CHEMBL210635 0.559 0.025 CHEMBL3526944 0.407 0.046 CHEMBL3526945 | CHEMBL210635 | |
| 0.777 | 0.019 | 0.786 | Apoptosis agonist | 0.786 0.018 CHEMBL210635 0.591 0.051 CHEMBL3526944 0.616 0.046 CHEMBL3526945 | CHEMBL210635 | |
| 0.745 | 0.003 | 0.745 | Breast cancer-resistant protein inhibitor | 0.684 0.004 CHEMBL210635 0.621 0.004 CHEMBL3526944 0.657 0.004 CHEMBL3526945 | ||
| 0.738 | 0.005 | 0.738 | Caspase 3 stimulant | 0.726 0.005 CHEMBL210635 0.414 0.04 CHEMBL3526944 0.308 0.075 CHEMBL3526945 | ||
| 0.722 | 0.003 | 0.77 | GABA C receptor rho-3 antagonist | 0.77 0.002 CHEMBL210635 0.545 0.015 CHEMBL3526944 0.507 0.024 CHEMBL3526945 | CHEMBL210635 | |
| 0.717 | 0.004 | 0.768 | Histamine release inhibitor | 0.768 0.004 CHEMBL210635 0.708 0.005 CHEMBL3526944 0.657 0.006 CHEMBL3526945 | CHEMBL210635 | |
| 0.702 | 0.002 | 0.889 | Cystathionine beta-synthase inhibitor | 0.889 0.001 CHEMBL210635 0.385 0.005 CHEMBL3526944 0.285 0.011 CHEMBL3526945 | CHEMBL210635 | |
| 0.698 | 0.005 | 0.772 | Free radical scavenger | 0.772 0.004 CHEMBL210635 0.608 0.008 CHEMBL3526944 0.555 0.011 CHEMBL3526945 | CHEMBL210635 | |
| 0.695 | 0.004 | 0.695 | 5 Hydroxytryptamine release inhibitor | 0.659 0.005 CHEMBL210635 0.304 0.16 CHEMBL3526944 0.34 0.124 CHEMBL3526945 | ||
| 0.684 | 0.005 | 0.729 | Amyloid beta aggregation inhibitor | 0.729 0.005 CHEMBL210635 0.481 0.016 CHEMBL3526944 0.417 0.022 CHEMBL3526945 | CHEMBL210635 | |
| 0.675 | 0.007 | 0.757 | Antioxidant | 0.757 0.005 CHEMBL210635 0.732 0.005 CHEMBL3526944 0.695 0.006 CHEMBL3526945 | CHEMBL210635 | |
| 0.629 | 0.005 | 0.629 | P-glycoprotein inhibitor | 0.57 0.005 CHEMBL210635 0.242 0.044 CHEMBL3526944 0.243 0.044 CHEMBL3526945 | ||
| 0.607 | 0.006 | 0.758 | Superoxide dismutase inhibitor | 0.685 0.004 CHEMBL210635 0.756 0.004 CHEMBL3526944 0.758 0.003 CHEMBL3526945 | CHEMBL3526945 | |
| 0.588 | 0.025 | 0.752 | 15-Lipoxygenase inhibitor | 0.752 0.009 CHEMBL210635 0.66 0.016 CHEMBL3526944 0.533 0.034 CHEMBL3526945 | CHEMBL210635 | |
| 0.557 | 0.006 | 0.715 | Peroxidase inhibitor | 0.715 0.003 CHEMBL210635 0.522 0.008 CHEMBL3526944 0.408 0.019 CHEMBL3526945 | CHEMBL210635 | |
| 0.543 | 0.005 | 0.543 | Acetylcholinesterase inhibitor | 0.457 0.005 CHEMBL210635 0.2 0.033 CHEMBL3526944 0.192 0.035 CHEMBL3526945 | ||
| 0.522 | 0.003 | 0.611 | GABA C receptor rho-2 antagonist | 0.611 0.002 CHEMBL210635 0.24 0.014 CHEMBL3526944 0.228 0.017 CHEMBL3526945 | CHEMBL210635 | |
| 0.52 | 0.006 | 0.646 | MAO inhibitor | 0.646 0.005 CHEMBL210635 0.227 0.034 CHEMBL3526944 0.112 0.08 CHEMBL3526945 | CHEMBL210635 | |
| 0.549 | 0.038 | 0.669 | Transcription factor NF kappa B inhibitor | 0.669 0.024 CHEMBL210635 0.505 0.043 CHEMBL3526944 0.416 0.06 CHEMBL3526945 | CHEMBL210635 | |
| 0.526 | 0.019 | 0.766 | 12-Lipoxygenase inhibitor | 0.766 0.005 CHEMBL210635 0.356 0.055 CHEMBL3526944 0.258 0.105 CHEMBL3526945 | CHEMBL210635 | |
| 0.511 | 0.006 | 0.635 | Melanin inhibitor | 0.635 0.004 CHEMBL210635 0.235 0.031 CHEMBL3526944 0.18 0.052 CHEMBL3526945 | CHEMBL210635 | |
| 0.51 | 0.014 | 0.52 | Vasodilator, coronary | 0.52 0.013 CHEMBL210635 0.287 0.098 CHEMBL3526944 0.291 0.095 CHEMBL3526945 | CHEMBL210635 | |
| 0.496 | 0.004 | 0.592 | Interleukin 4 antagonist | 0.592 0.004 CHEMBL210635 0.213 0.019 CHEMBL3526944 0.158 0.043 CHEMBL3526945 | CHEMBL210635 | |
| 0.5 | 0.015 | 0.607 | Hypoxia-inducible factor 1 alpha inhibitor | 0.607 0.007 CHEMBL210635 0.359 0.042 CHEMBL3526944 0.29 0.07 CHEMBL3526945 | CHEMBL210635 | |
| 0.493 | 0.008 | 0.493 | Tubulin antagonist | 0.478 0.008 CHEMBL210635 0.224 0.03 CHEMBL3526944 0.228 0.029 CHEMBL3526945 | ||
| 0.544 | 0.068 | 0.7 | Alpha-glucosidase inhibitor | 0.7 0.034 CHEMBL210635 0.515 0.076 CHEMBL3526944 0.336 0.142 CHEMBL3526945 | CHEMBL210635 | |
| 0.479 | 0.006 | 0.479 | Cholinergic | 0.374 0.011 CHEMBL210635 0.125 0.102 CHEMBL3526944 0.123 0.104 CHEMBL3526945 | ||
| 0.475 | 0.005 | 0.63 | MAO A inhibitor | 0.63 0.004 CHEMBL210635 0.211 0.027 CHEMBL3526944 0.089 0.072 CHEMBL3526945 | CHEMBL210635 | |
| 0.485 | 0.017 | 0.567 | Antiamyloidogenic | 0.567 0.01 CHEMBL210635 0.326 0.045 CHEMBL3526944 0.234 0.079 CHEMBL3526945 | CHEMBL210635 | |
| 0.483 | 0.015 | 0.483 | Tumour necrosis factor alpha release inhibitor | 0.421 0.023 CHEMBL210635 0.319 0.047 CHEMBL3526944 0.278 0.062 CHEMBL3526945 | ||
| 0.462 | 0.004 | 0.623 | NADPH oxidase inhibitor | 0.623 0.003 CHEMBL210635 0.132 0.069 CHEMBL3526944 | CHEMBL210635 | |
| 0.458 | 0.007 | 0.636 | Amylase inhibitor | 0.636 0.004 CHEMBL210635 0.23 0.034 CHEMBL3526944 0.157 0.061 CHEMBL3526945 | CHEMBL210635 | |
| 0.471 | 0.023 | 0.647 | Lipoxygenase inhibitor | 0.647 0.007 CHEMBL210635 0.333 0.056 CHEMBL3526944 0.235 0.11 CHEMBL3526945 | CHEMBL210635 | |
| 0.451 | 0.005 | 0.501 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.501 0.004 CHEMBL210635 0.269 0.035 CHEMBL3526944 0.227 0.054 CHEMBL3526945 | CHEMBL210635 | |
| 0.457 | 0.02 | 0.5 | Hypoglycemic | 0.5 0.015 CHEMBL210635 0.199 0.113 CHEMBL3526944 | CHEMBL210635 | |
| 0.508 | 0.084 | 0.613 | Antiinflammatory | 0.579 0.059 CHEMBL210635 0.613 0.05 CHEMBL3526944 0.596 0.055 CHEMBL3526945 | CHEMBL3526944 | |
| 0.434 | 0.015 | 0.545 | RNA-directed DNA polymerase inhibitor | 0.483 0.012 CHEMBL210635 0.545 0.008 CHEMBL3526944 0.521 0.01 CHEMBL3526945 | CHEMBL3526944 | |
| 0.425 | 0.006 | 0.524 | MAO B inhibitor | 0.524 0.005 CHEMBL210635 0.141 0.041 CHEMBL3526944 | CHEMBL210635 | |
| 0.423 | 0.005 | 0.423 | Tumour necrosis factor antagonist | 0.374 0.008 CHEMBL210635 0.132 0.125 CHEMBL3526945 | ||
| 0.439 | 0.021 | 0.472 | DNA damaging | 0.472 0.017 CHEMBL210635 0.279 0.066 CHEMBL3526944 0.264 0.073 CHEMBL3526945 | CHEMBL210635 | |
| 0.432 | 0.018 | 0.432 | Vasodilator | 0.407 0.022 CHEMBL210635 0.2 0.104 CHEMBL3526944 0.243 0.073 CHEMBL3526945 | ||
| 0.432 | 0.022 | 0.469 | Nitric oxide antagonist | 0.469 0.018 CHEMBL210635 0.338 0.034 CHEMBL3526944 0.307 0.039 CHEMBL3526945 | CHEMBL210635 | |
| 0.417 | 0.011 | 0.417 | 5 Hydroxytryptamine uptake stimulant | 0.4 0.014 CHEMBL210635 0.2 0.152 CHEMBL3526944 0.208 0.137 CHEMBL3526945 | ||
| 0.415 | 0.018 | 0.537 | Pyruvate kinase inhibitor | 0.537 0.006 CHEMBL210635 0.236 0.065 CHEMBL3526944 0.167 0.102 CHEMBL3526945 | CHEMBL210635 | |
| 0.431 | 0.034 | 0.498 | Spasmolytic | 0.498 0.023 CHEMBL210635 0.432 0.034 CHEMBL3526944 0.33 0.059 CHEMBL3526945 | CHEMBL210635 | |
| 0.434 | 0.039 | 0.45 | 5 Hydroxytryptamine release stimulant | 0.45 0.036 CHEMBL210635 | CHEMBL210635 | |
| 0.447 | 0.052 | 0.496 | Calcium channel L-type activator | 0.496 0.029 CHEMBL210635 0.244 0.212 CHEMBL3526944 | CHEMBL210635 | |
| 0.406 | 0.014 | 0.589 | Dual specificity phosphatase inhibitor | 0.438 0.011 CHEMBL210635 0.589 0.005 CHEMBL3526944 0.589 0.005 CHEMBL3526945 | CHEMBL3526945 | |
| 0.396 | 0.012 | 0.634 | Monophenol monooxygenase inhibitor | 0.634 0.005 CHEMBL210635 0.46 0.009 CHEMBL3526944 0.297 0.018 CHEMBL3526945 | CHEMBL210635 | |
| 0.416 | 0.034 | 0.475 | Apoptosis antagonist | 0.475 0.024 CHEMBL210635 0.254 0.124 CHEMBL3526944 0.198 0.181 CHEMBL3526945 | CHEMBL210635 | |
| 0.381 | 0.005 | 0.559 | Xanthine oxidase inhibitor | 0.559 0.003 CHEMBL210635 0.215 0.017 CHEMBL3526944 0.158 0.031 CHEMBL3526945 | CHEMBL210635 | |
| 0.385 | 0.011 | 0.448 | Topoisomerase II inhibitor | 0.448 0.008 CHEMBL210635 0.284 0.02 CHEMBL3526944 0.294 0.019 CHEMBL3526945 | CHEMBL210635 | |
| 0.379 | 0.007 | 0.379 | Butyrylcholinesterase inhibitor | 0.288 0.011 CHEMBL210635 | ||
| 0.396 | 0.026 | 0.396 | Calcium channel activator | 0.334 0.061 CHEMBL210635 0.211 0.197 CHEMBL3526945 | ||
| 0.425 | 0.059 | 0.481 | Prostaglandin dehydrogenase inhibitor | 0.481 0.046 CHEMBL210635 | CHEMBL210635 | |
| 0.381 | 0.019 | 0.381 | Cyclic AMP phosphodiesterase inhibitor | 0.377 0.02 CHEMBL210635 | ||
| 0.373 | 0.017 | 0.579 | Dual specificity phosphatase 3 inhibitor | 0.398 0.014 CHEMBL210635 0.571 0.005 CHEMBL3526944 0.579 0.005 CHEMBL3526945 | CHEMBL3526945 | |
| 0.36 | 0.005 | 0.389 | Topoisomerase II alpha inhibitor | 0.389 0.005 CHEMBL210635 0.203 0.014 CHEMBL3526944 0.159 0.022 CHEMBL3526945 | CHEMBL210635 | |
| 0.357 | 0.005 | 0.414 | Nitric-oxide synthase stimulant | 0.414 0.003 CHEMBL210635 0.227 0.052 CHEMBL3526944 0.208 0.076 CHEMBL3526945 | CHEMBL210635 | |
| 0.351 | 0.003 | 0.55 | Creatine kinase inhibitor | 0.55 0.002 CHEMBL210635 0.337 0.004 CHEMBL3526944 0.243 0.006 CHEMBL3526945 | CHEMBL210635 | |
| 0.362 | 0.017 | 0.399 | Hepatoprotectant | 0.399 0.013 CHEMBL210635 0.385 0.015 CHEMBL3526944 0.372 0.016 CHEMBL3526945 | CHEMBL210635 | |
| 0.347 | 0.004 | 0.493 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.493 0.002 CHEMBL210635 0.256 0.006 CHEMBL3526944 0.179 0.012 CHEMBL3526945 | CHEMBL210635 | |
| 0.345 | 0.003 | 0.384 | Multidrug resistance-associated protein 1 inhibitor | 0.323 0.004 CHEMBL210635 0.38 0.003 CHEMBL3526944 0.384 0.003 CHEMBL3526945 | CHEMBL3526945 | |
| 0.369 | 0.045 | 0.448 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.448 0.028 CHEMBL210635 | CHEMBL210635 | |
| 0.339 | 0.035 | 0.339 | Antimitotic | 0.311 0.041 CHEMBL210635 0.17 0.103 CHEMBL3526944 0.244 0.062 CHEMBL3526945 | ||
| 0.318 | 0.015 | 0.365 | Protein kinase stimulant | 0.365 0.011 CHEMBL210635 | CHEMBL210635 | |
| 0.312 | 0.016 | 0.429 | NOS3 expression enhancer | 0.429 0.007 CHEMBL210635 0.245 0.028 CHEMBL3526944 0.186 0.047 CHEMBL3526945 | CHEMBL210635 | |
| 0.304 | 0.008 | 0.406 | Carbonic anhydrase XV inhibitor | 0.406 0.004 CHEMBL210635 0.284 0.009 CHEMBL3526944 0.242 0.013 CHEMBL3526945 | CHEMBL210635 | |
| 0.303 | 0.011 | 0.498 | Aldehyde dehydrogenase inhibitor | 0.498 0.004 CHEMBL210635 0.159 0.042 CHEMBL3526944 0.101 0.096 CHEMBL3526945 | CHEMBL210635 | |
| 0.291 | 0.004 | 0.341 | GABA C receptor rho-1 antagonist | 0.341 0.003 CHEMBL210635 0.119 0.04 CHEMBL3526944 0.119 0.04 CHEMBL3526945 | CHEMBL210635 | |
| 0.293 | 0.006 | 0.461 | Beta glucuronidase inhibitor | 0.461 0.004 CHEMBL210635 0.137 0.032 CHEMBL3526944 0.107 0.06 CHEMBL3526945 | CHEMBL210635 | |
| 0.315 | 0.029 | 0.465 | Platelet adhesion inhibitor | 0.315 0.029 CHEMBL210635 0.465 0.007 CHEMBL3526944 0.449 0.008 CHEMBL3526945 | CHEMBL3526944 | |
| 0.302 | 0.019 | 0.415 | Lipid peroxidase inhibitor | 0.415 0.009 CHEMBL210635 0.328 0.015 CHEMBL3526944 0.271 0.023 CHEMBL3526945 | CHEMBL210635 | |
| 0.293 | 0.013 | 0.53 | Alkaline phosphatase inhibitor | 0.382 0.006 CHEMBL210635 0.53 0.004 CHEMBL3526944 0.325 0.009 CHEMBL3526945 | CHEMBL3526944 | |
| 0.281 | 0.007 | 0.857 | Carbonic anhydrase XIII inhibitor | 0.363 0.004 CHEMBL210635 0.857 0.002 CHEMBL3526944 0.67 0.003 CHEMBL3526945 | CHEMBL3526944 | |
| 0.276 | 0.005 | 0.276 | Electron transport complex I inhibitor | 0.208 0.008 CHEMBL210635 0.119 0.048 CHEMBL3526944 0.12 0.047 CHEMBL3526945 | ||
| 0.272 | 0.005 | 0.309 | Aldose reductase inhibitor | 0.309 0.004 CHEMBL210635 0.262 0.005 CHEMBL3526944 0.235 0.005 CHEMBL3526945 | CHEMBL210635 | |
| 0.285 | 0.022 | 0.523 | Protein-tyrosine phosphatase inhibitor | 0.324 0.015 CHEMBL210635 0.498 0.005 CHEMBL3526944 0.523 0.005 CHEMBL3526945 | CHEMBL3526945 | |
| 0.26 | 0.008 | 0.471 | Carbonic anhydrase III inhibitor | 0.466 0.003 CHEMBL210635 0.471 0.003 CHEMBL3526944 0.27 0.007 CHEMBL3526945 | CHEMBL3526944 | |
| 0.265 | 0.014 | 0.353 | 5-Lipoxygenase inhibitor | 0.353 0.007 CHEMBL210635 0.09 0.072 CHEMBL3526944 | CHEMBL210635 | |
| 0.304 | 0.053 | 0.348 | Transcription factor STAT inhibitor | 0.348 0.035 CHEMBL210635 | CHEMBL210635 | |
| 0.279 | 0.033 | 0.328 | Non-steroidal antiinflammatory agent | 0.328 0.023 CHEMBL210635 0.178 0.089 CHEMBL3526944 0.171 0.094 CHEMBL3526945 | CHEMBL210635 | |
| 0.265 | 0.023 | 0.265 | Cyclooxygenase inhibitor | 0.265 0.023 CHEMBL210635 0.199 0.042 CHEMBL3526944 0.171 0.056 CHEMBL3526945 | ||
| 0.283 | 0.042 | 0.283 | 5 Hydroxytryptamine 1E antagonist | 0.281 0.044 CHEMBL210635 | ||
| 0.246 | 0.007 | 0.302 | CF transmembrane conductance regulator agonist | 0.302 0.004 CHEMBL210635 0.135 0.106 CHEMBL3526944 | CHEMBL210635 | |
| 0.266 | 0.027 | 0.275 | Amyloid beta precursor protein antagonist | 0.275 0.024 CHEMBL210635 0.164 0.087 CHEMBL3526944 0.151 0.1 CHEMBL3526945 | CHEMBL210635 | |
| 0.241 | 0.007 | 0.312 | GABA C receptor antagonist | 0.312 0.004 CHEMBL210635 0.211 0.011 CHEMBL3526944 0.196 0.014 CHEMBL3526945 | CHEMBL210635 | |
| 0.256 | 0.025 | 0.256 | 3C-like protease (Human coronavirus) inhibitor | 0.166 0.078 CHEMBL210635 | ||
| 0.239 | 0.008 | 0.255 | Uric acid excretion stimulant | 0.255 0.007 CHEMBL210635 0.115 0.041 CHEMBL3526944 0.095 0.058 CHEMBL3526945 | CHEMBL210635 | |
| 0.232 | 0.004 | 0.232 | Protease activated receptor antagonist | 0.124 0.008 CHEMBL210635 0.058 0.05 CHEMBL3526944 0.066 0.038 CHEMBL3526945 | ||
| 0.266 | 0.04 | 0.316 | DNA methyltransferase I inhibitor | 0.316 0.021 CHEMBL210635 | CHEMBL210635 | |
| 0.228 | 0.005 | 0.242 | Cyclin B3 inhibitor | 0.242 0.004 CHEMBL210635 0.105 0.026 CHEMBL3526944 0.076 0.041 CHEMBL3526945 | CHEMBL210635 | |
| 0.333 | 0.113 | 0.562 | Antibacterial | 0.441 0.06 CHEMBL210635 0.562 0.026 CHEMBL3526944 0.551 0.028 CHEMBL3526945 | CHEMBL3526944 | |
| 0.254 | 0.036 | 0.254 | I kappa B kinase epsilon inhibitor | 0.238 0.044 CHEMBL210635 | ||
| 0.352 | 0.138 | 0.381 | DNA polymerase beta inhibitor | 0.381 0.127 CHEMBL210635 | CHEMBL210635 | |
| 0.233 | 0.02 | 0.368 | Protein-tyrosine phosphatase 1B inhibitor | 0.261 0.015 CHEMBL210635 0.355 0.007 CHEMBL3526944 0.368 0.007 CHEMBL3526945 | CHEMBL3526945 | |
| 0.281 | 0.071 | 0.295 | Insulysin inhibitor | 0.295 0.062 CHEMBL210635 | CHEMBL210635 | |
| 0.218 | 0.011 | 0.399 | Carbonic anhydrase VI inhibitor | 0.392 0.004 CHEMBL210635 0.399 0.004 CHEMBL3526944 0.229 0.01 CHEMBL3526945 | CHEMBL3526944 | |
| 0.232 | 0.025 | 0.258 | Cyclooxygenase 1 inhibitor | 0.258 0.02 CHEMBL210635 0.243 0.023 CHEMBL3526944 0.206 0.032 CHEMBL3526945 | CHEMBL210635 | |
| 0.235 | 0.028 | 0.245 | Succinate dehydrogenase inhibitor | 0.245 0.024 CHEMBL210635 0.181 0.066 CHEMBL3526944 0.182 0.065 CHEMBL3526945 | CHEMBL210635 | |
| 0.214 | 0.01 | 0.214 | Phosphodiesterase 4D inhibitor | 0.159 0.017 CHEMBL210635 | ||
| 0.228 | 0.024 | 0.228 | Cyclooxygenase 2 inhibitor | 0.219 0.026 CHEMBL210635 0.191 0.034 CHEMBL3526944 0.173 0.041 CHEMBL3526945 | ||
| 0.216 | 0.012 | 0.216 | Telomerase inhibitor | 0.167 0.018 CHEMBL210635 | ||
| 0.261 | 0.058 | 0.313 | Tyrosine 3 hydroxylase inhibitor | 0.313 0.027 CHEMBL210635 | CHEMBL210635 | |
| 0.261 | 0.063 | 0.348 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.348 0.036 CHEMBL210635 | CHEMBL210635 | |
| 0.203 | 0.008 | 0.203 | DNA repair enzyme inhibitor | 0.199 0.009 CHEMBL210635 0.136 0.046 CHEMBL3526944 0.157 0.026 CHEMBL3526945 | ||
| 0.2 | 0.005 | 0.22 | Myeloperoxidase inhibitor | 0.22 0.005 CHEMBL210635 | CHEMBL210635 | |
| 0.199 | 0.004 | 0.303 | Xanthine dehydrogenase inhibitor | 0.303 0.003 CHEMBL210635 0.081 0.024 CHEMBL3526944 0.053 0.044 CHEMBL3526945 | CHEMBL210635 | |
| 0.2 | 0.009 | 0.249 | Aromatase inhibitor | 0.249 0.006 CHEMBL210635 0.176 0.01 CHEMBL3526944 0.1 0.021 CHEMBL3526945 | CHEMBL210635 | |
| 0.215 | 0.023 | 0.215 | Mannose-6-phosphate isomerase inhibitor | 0.196 0.033 CHEMBL210635 | ||
| 0.203 | 0.018 | 0.221 | Cyclooxygenase 3 inhibitor | 0.221 0.013 CHEMBL210635 | CHEMBL210635 | |
| 0.232 | 0.046 | 0.251 | Insulin sensitizer | 0.251 0.034 CHEMBL210635 0.195 0.078 CHEMBL3526944 0.145 0.14 CHEMBL3526945 | CHEMBL210635 | |
| 0.239 | 0.054 | 0.287 | DNA methylase inhibitor | 0.287 0.032 CHEMBL210635 | CHEMBL210635 | |
| 0.195 | 0.011 | 0.195 | Sphingomyelinase inhibitor | 0.189 0.012 CHEMBL210635 0.087 0.076 CHEMBL3526945 | ||
| 0.198 | 0.015 | 0.229 | Mediator release inhibitor | 0.229 0.011 CHEMBL210635 | CHEMBL210635 | |
| 0.203 | 0.021 | 0.204 | Antibacterial (Helicobacter pylori) | 0.204 0.021 CHEMBL210635 0.191 0.024 CHEMBL3526944 0.152 0.045 CHEMBL3526945 | CHEMBL210635 | |
| 0.248 | 0.071 | 0.559 | Angiogenesis stimulant | 0.328 0.039 CHEMBL210635 0.559 0.009 CHEMBL3526944 0.553 0.009 CHEMBL3526945 | CHEMBL3526944 | |
| 0.192 | 0.014 | 0.378 | Histidine decarboxylase inhibitor | 0.378 0.004 CHEMBL210635 | CHEMBL210635 | |
| 0.209 | 0.031 | 0.317 | M18 aspartyl aminopeptidase inhibitor | 0.317 0.01 CHEMBL210635 0.108 0.082 CHEMBL3526944 | CHEMBL210635 | |
| 0.182 | 0.005 | 0.205 | Histone deacetylase SIRT1 stimulant | 0.205 0.005 CHEMBL210635 | CHEMBL210635 | |
| 0.182 | 0.005 | 0.205 | Histone deacetylase stimulant | 0.205 0.005 CHEMBL210635 | CHEMBL210635 | |
| 0.195 | 0.018 | 0.195 | Beta amyloid protein antagonist | 0.153 0.039 CHEMBL210635 | ||
| 0.19 | 0.015 | 0.212 | Photosensitizer | 0.212 0.011 CHEMBL210635 0.118 0.06 CHEMBL3526944 0.108 0.074 CHEMBL3526945 | CHEMBL210635 | |
| 0.237 | 0.067 | 0.313 | Interleukin antagonist | 0.313 0.045 CHEMBL210635 | CHEMBL210635 | |
| 0.232 | 0.063 | 0.25 | MAP kinase kinase 2 inhibitor | 0.25 0.054 CHEMBL210635 | CHEMBL210635 | |
| 0.2 | 0.033 | 0.2 | Interleukin 1 antagonist | 0.16 0.051 CHEMBL210635 | ||
| 0.32 | 0.152 | 0.368 | DNA directed DNA polymerase inhibitor | 0.368 0.13 CHEMBL210635 | CHEMBL210635 | |
| 0.223 | 0.057 | 0.297 | Neurotrophic factor enhancer | 0.297 0.019 CHEMBL210635 | CHEMBL210635 | |
| 0.178 | 0.013 | 0.215 | Heat shock protein 70 antagonist | 0.215 0.005 CHEMBL210635 | CHEMBL210635 | |
| 0.177 | 0.011 | 0.255 | DOPA decarboxylase inhibitor | 0.255 0.004 CHEMBL210635 0.124 0.041 CHEMBL3526944 0.097 0.081 CHEMBL3526945 | CHEMBL210635 | |
| 0.18 | 0.016 | 0.197 | Papain-like protease (SARS coronavirus) inhibitor | 0.197 0.011 CHEMBL210635 0.123 0.075 CHEMBL3526944 0.118 0.086 CHEMBL3526945 | CHEMBL210635 | |
| 0.274 | 0.111 | 0.274 | Vasodilator, peripheral | 0.244 0.131 CHEMBL210635 | ||
| 0.198 | 0.039 | 0.305 | Heat shock protein 90 antagonist | 0.305 0.009 CHEMBL210635 | CHEMBL210635 | |
| 0.189 | 0.03 | 0.226 | Alkylator | 0.226 0.02 CHEMBL210635 0.192 0.029 CHEMBL3526944 0.207 0.024 CHEMBL3526945 | CHEMBL210635 | |
| 0.237 | 0.078 | 0.316 | Dyrk kinase inhibitor | 0.316 0.047 CHEMBL210635 | CHEMBL210635 | |
| 0.209 | 0.051 | 0.246 | Mcl-1 antagonist | 0.246 0.037 CHEMBL210635 | CHEMBL210635 | |
| 0.187 | 0.03 | 0.258 | Topoisomerase I inhibitor | 0.258 0.015 CHEMBL210635 0.163 0.037 CHEMBL3526944 0.178 0.032 CHEMBL3526945 | CHEMBL210635 | |
| 0.169 | 0.011 | 0.304 | Macrophage migration inhibitory factor inhibitor | 0.304 0.004 CHEMBL210635 0.126 0.023 CHEMBL3526944 0.077 0.055 CHEMBL3526945 | CHEMBL210635 | |
| 0.204 | 0.047 | 0.303 | Heat shock protein 90 alpha antagonist | 0.303 0.014 CHEMBL210635 | CHEMBL210635 | |
| 0.173 | 0.017 | 0.379 | Estrogen antagonist | 0.379 0.005 CHEMBL210635 0.157 0.021 CHEMBL3526944 0.13 0.039 CHEMBL3526945 | CHEMBL210635 | |
| 0.197 | 0.042 | 0.271 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.271 0.024 CHEMBL210635 | CHEMBL210635 | |
| 0.193 | 0.038 | 0.193 | Cytokine production inhibitor | 0.134 0.076 CHEMBL210635 | ||
| 0.193 | 0.039 | 0.217 | Neurotensin receptor agonist | 0.217 0.028 CHEMBL210635 | CHEMBL210635 | |
| 0.181 | 0.028 | 0.348 | Chelator | 0.348 0.008 CHEMBL210635 0.116 0.057 CHEMBL3526944 | CHEMBL210635 | |
| 0.161 | 0.008 | 0.161 | Thioredoxin reductase inhibitor | 0.149 0.009 CHEMBL210635 0.09 0.041 CHEMBL3526944 0.084 0.053 CHEMBL3526945 | ||
| 0.156 | 0.005 | 0.156 | DNA-dependent protein kinase inhibitor | 0.089 0.008 CHEMBL210635 | ||
| 0.156 | 0.005 | 0.234 | D-Ala-D-Ala ligase inhibitor | 0.234 0.003 CHEMBL210635 0.106 0.023 CHEMBL3526944 0.09 0.045 CHEMBL3526945 | CHEMBL210635 | |
| 0.169 | 0.018 | 0.169 | Phosphodiesterase IV inhibitor | 0.103 0.043 CHEMBL210635 | ||
| 0.158 | 0.009 | 0.266 | Alpha tubulin antagonist | 0.266 0.005 CHEMBL210635 0.127 0.012 CHEMBL3526944 0.048 0.044 CHEMBL3526945 | CHEMBL210635 | |
| 0.162 | 0.013 | 0.399 | Estrogen receptor beta antagonist | 0.399 0.004 CHEMBL210635 0.156 0.014 CHEMBL3526944 0.123 0.029 CHEMBL3526945 | CHEMBL210635 | |
| 0.153 | 0.006 | 0.259 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.259 0.003 CHEMBL210635 0.074 0.028 CHEMBL3526944 | CHEMBL210635 | |
| 0.156 | 0.01 | 0.156 | Interleukin 5 antagonist | 0.139 0.014 CHEMBL210635 | ||
| 0.177 | 0.03 | 0.225 | Protein kinase (CK2) alpha inhibitor | 0.225 0.02 CHEMBL210635 | CHEMBL210635 | |
| 0.203 | 0.058 | 0.203 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.159 | 0.014 | 0.173 | Thioredoxin inhibitor | 0.173 0.012 CHEMBL210635 0.12 0.03 CHEMBL3526944 0.094 0.056 CHEMBL3526945 | CHEMBL210635 | |
| 0.155 | 0.011 | 0.23 | Beta tubulin antagonist | 0.23 0.006 CHEMBL210635 0.069 0.035 CHEMBL3526944 | CHEMBL210635 | |
| 0.163 | 0.019 | 0.163 | Calcium antagonist | 0.076 0.067 CHEMBL210635 | ||
| 0.148 | 0.005 | 0.148 | Aryl hydrocarbon receptor antagonist | 0.144 0.005 CHEMBL210635 | ||
| 0.151 | 0.013 | 0.264 | CDC25A inhibitor | 0.172 0.009 CHEMBL210635 0.258 0.004 CHEMBL3526944 0.264 0.004 CHEMBL3526945 | CHEMBL3526945 | |
| 0.142 | 0.004 | 0.158 | GABA B receptor antagonist | 0.158 0.004 CHEMBL210635 0.052 0.018 CHEMBL3526944 0.054 0.016 CHEMBL3526945 | CHEMBL210635 | |
| 0.322 | 0.184 | 0.322 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.183 | 0.046 | 0.195 | Insulin secretagoues | 0.195 0.039 CHEMBL210635 | CHEMBL210635 | |
| 0.243 | 0.107 | 0.35 | Streptokinase A inhibitor | 0.35 0.062 CHEMBL210635 | CHEMBL210635 | |
| 0.155 | 0.02 | 0.187 | Urease inhibitor | 0.187 0.012 CHEMBL210635 0.094 0.074 CHEMBL3526944 | CHEMBL210635 | |
| 0.146 | 0.012 | 0.363 | Estrogen receptor alpha antagonist | 0.363 0.004 CHEMBL210635 0.106 0.024 CHEMBL3526944 0.082 0.046 CHEMBL3526945 | CHEMBL210635 | |
| 0.137 | 0.004 | 0.137 | Glutamate (mGluR7) antagonist | 0.116 0.005 CHEMBL210635 | ||
| 0.208 | 0.076 | 0.226 | Psychostimulant | 0.226 0.068 CHEMBL210635 | CHEMBL210635 | |
| 0.181 | 0.05 | 0.234 | Interferon gamma antagonist | 0.234 0.031 CHEMBL210635 | CHEMBL210635 | |
| 0.231 | 0.1 | 0.254 | Transcription factor STAT3 inhibitor | 0.254 0.08 CHEMBL210635 | CHEMBL210635 | |
| 0.134 | 0.003 | 0.137 | Transcription factor RelA inhibitor | 0.137 0.003 CHEMBL210635 0.077 0.02 CHEMBL3526944 0.074 0.024 CHEMBL3526945 | CHEMBL210635 | |
| 0.181 | 0.053 | 0.185 | Arachidonic acid antagonist | 0.185 0.048 CHEMBL210635 | CHEMBL210635 | |
| 0.145 | 0.018 | 0.145 | CYP2A6 inhibitor | 0.097 0.037 CHEMBL210635 | ||
| 0.132 | 0.01 | 0.132 | Granulocyte macrophage colony stimulating factor agonist | 0.112 0.022 CHEMBL210635 | ||
| 0.138 | 0.017 | 0.215 | Keratolytic | 0.215 0.007 CHEMBL210635 | CHEMBL210635 | |
| 0.247 | 0.126 | 0.27 | Thyroid hormone antagonist | 0.27 0.111 CHEMBL210635 | CHEMBL210635 | |
| 0.246 | 0.126 | 0.57 | Angiogenesis inhibitor | 0.251 0.122 CHEMBL210635 0.508 0.028 CHEMBL3526944 0.57 0.02 CHEMBL3526945 | CHEMBL3526945 | |
| 0.243 | 0.123 | 0.258 | Thyroid hormone beta antagonist | 0.258 0.113 CHEMBL210635 | CHEMBL210635 | |
| 0.136 | 0.018 | 0.471 | Carbonic anhydrase V inhibitor | 0.172 0.01 CHEMBL210635 0.471 0.003 CHEMBL3526944 0.34 0.003 CHEMBL3526945 | CHEMBL3526944 | |
| 0.121 | 0.005 | 0.121 | Potassium channel Kv1.3 blocker | 0.093 0.009 CHEMBL210635 | ||
| 0.123 | 0.008 | 0.199 | Carbonic anhydrase VII inhibitor | 0.199 0.005 CHEMBL210635 0.098 0.01 CHEMBL3526944 0.053 0.024 CHEMBL3526945 | CHEMBL210635 | |
| 0.119 | 0.007 | 0.176 | Fatty acid synthase inhibitor | 0.176 0.004 CHEMBL210635 | CHEMBL210635 | |
| 0.127 | 0.016 | 0.317 | Carbonic anhydrase VA inhibitor | 0.157 0.009 CHEMBL210635 0.317 0.003 CHEMBL3526944 0.241 0.004 CHEMBL3526945 | CHEMBL3526944 | |
| 0.115 | 0.005 | 0.115 | Cyclin D1 inhibitor | 0.109 0.005 CHEMBL210635 | ||
| 0.125 | 0.015 | 0.125 | mTOR complex 2 inhibitor | 0.104 0.028 CHEMBL210635 | ||
| 0.169 | 0.06 | 0.171 | Phospholipase A2 inhibitor | 0.171 0.059 CHEMBL210635 0.133 0.096 CHEMBL3526944 0.127 0.106 CHEMBL3526945 | CHEMBL210635 | |
| 0.161 | 0.051 | 0.219 | Bone formation stimulant | 0.219 0.031 CHEMBL210635 0.139 0.068 CHEMBL3526945 | CHEMBL210635 | |
| 0.14 | 0.032 | 0.161 | Transcription factor STAT6 inhibitor | 0.161 0.016 CHEMBL210635 | CHEMBL210635 | |
| 0.129 | 0.02 | 0.135 | Ornithine decarboxylase inhibitor | 0.135 0.017 CHEMBL210635 | CHEMBL210635 | |
| 0.174 | 0.066 | 0.199 | ATPase inhibitor | 0.199 0.038 CHEMBL210635 | CHEMBL210635 | |
| 0.284 | 0.177 | 0.393 | Cyclophilin D inhibitor | 0.34 0.13 CHEMBL210635 0.393 0.095 CHEMBL3526944 0.343 0.128 CHEMBL3526945 | CHEMBL3526944 | |
| 0.15 | 0.043 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.146 0.052 CHEMBL210635 | ||
| 0.143 | 0.036 | 0.161 | TRPA1 agonist | 0.161 0.024 CHEMBL210635 0.14 0.039 CHEMBL3526944 0.157 0.026 CHEMBL3526945 | CHEMBL210635 | |
| 0.24 | 0.134 | 0.477 | Antithrombotic | 0.266 0.114 CHEMBL210635 0.477 0.032 CHEMBL3526944 0.412 0.046 CHEMBL3526945 | CHEMBL3526944 | |
| 0.141 | 0.038 | 0.166 | Mucolytic | 0.166 0.024 CHEMBL210635 | CHEMBL210635 | |
| 0.107 | 0.004 | 0.107 | Ryanodine receptor antagonist | 0.102 0.004 CHEMBL210635 | ||
| 0.133 | 0.03 | 0.165 | Acetylcholine release stimulant | 0.105 0.075 CHEMBL210635 0.134 0.03 CHEMBL3526944 0.165 0.009 CHEMBL3526945 | CHEMBL3526945 | |
| 0.106 | 0.009 | 0.106 | CD45 antagonist | 0.095 0.01 CHEMBL210635 | ||
| 0.162 | 0.065 | 0.205 | Hexokinase inhibitor | 0.205 0.032 CHEMBL210635 | CHEMBL210635 | |
| 0.144 | 0.048 | 0.266 | Cholesterol synthesis inhibitor | 0.203 0.026 CHEMBL210635 0.266 0.015 CHEMBL3526944 0.233 0.02 CHEMBL3526945 | CHEMBL3526944 | |
| 0.142 | 0.046 | 0.142 | Interleukin 1b antagonist | |||
| 0.186 | 0.09 | 0.19 | Histone acetyltransferase inhibitor | 0.19 0.084 CHEMBL210635 | CHEMBL210635 | |
| 0.156 | 0.061 | 0.501 | Hemostatic | 0.173 0.046 CHEMBL210635 0.485 0.005 CHEMBL3526944 0.501 0.004 CHEMBL3526945 | CHEMBL3526945 | |
| 0.125 | 0.031 | 0.164 | Androgen antagonist | 0.164 0.019 CHEMBL210635 | CHEMBL210635 | |
| 0.102 | 0.01 | 0.264 | Estradiol 17 beta-dehydrogenase inhibitor | 0.264 0.004 CHEMBL210635 0.063 0.018 CHEMBL3526944 | CHEMBL210635 | |
| 0.121 | 0.032 | 0.272 | Protein kinase C zeta inhibitor | 0.178 0.014 CHEMBL210635 0.272 0.006 CHEMBL3526944 0.208 0.01 CHEMBL3526945 | CHEMBL3526944 | |
| 0.145 | 0.056 | 0.197 | Toll-Like receptor 2 antagonist | 0.197 0.025 CHEMBL210635 | CHEMBL210635 | |
| 0.127 | 0.044 | 0.163 | Protein kinase (CK2) inhibitor | 0.163 0.028 CHEMBL210635 | CHEMBL210635 | |
| 0.128 | 0.045 | 0.128 | Nav1.5 sodium channel blocker | |||
| 0.213 | 0.13 | 0.213 | Gastrin inhibitor | 0.193 0.159 CHEMBL210635 | ||
| 0.128 | 0.045 | 0.164 | Expectorant | 0.164 0.03 CHEMBL210635 | CHEMBL210635 | |
| 0.111 | 0.03 | 0.245 | Cathepsin G inhibitor | 0.087 0.039 CHEMBL210635 0.245 0.013 CHEMBL3526944 0.227 0.014 CHEMBL3526945 | CHEMBL3526944 | |
| 0.105 | 0.024 | 0.105 | Caspase 7 inhibitor | 0.082 0.056 CHEMBL210635 | ||
| 0.1 | 0.02 | 0.1 | Phosphodiesterase VI inhibitor | 0.09 0.028 CHEMBL210635 | ||
| 0.124 | 0.044 | 0.124 | Cyclin-dependent kinase 9 inhibitor | 0.107 0.055 CHEMBL210635 | ||
| 0.13 | 0.051 | 0.13 | Microtubule formation inhibitor | 0.123 0.057 CHEMBL210635 | ||
| 0.125 | 0.046 | 0.125 | Alpha 2c adrenoreceptor antagonist | 0.093 0.072 CHEMBL210635 | ||
| 0.096 | 0.017 | 0.25 | Carbonic anhydrase VB inhibitor | 0.136 0.01 CHEMBL210635 0.25 0.004 CHEMBL3526944 0.197 0.005 CHEMBL3526945 | CHEMBL3526944 | |
| 0.116 | 0.038 | 0.204 | Alcohol dehydrogenase inhibitor | 0.204 0.012 CHEMBL210635 | CHEMBL210635 | |
| 0.156 | 0.08 | 0.174 | Interleukin 6 antagonist | 0.174 0.06 CHEMBL210635 | CHEMBL210635 | |
| 0.123 | 0.047 | 0.178 | AMP-activated protein kinase stimulant | 0.178 0.015 CHEMBL210635 | CHEMBL210635 | |
| 0.102 | 0.027 | 0.102 | Phosphodiesterase V inhibitor | |||
| 0.08 | 0.007 | 0.08 | Cholesterol esterase inhibitor | 0.071 0.01 CHEMBL210635 | ||
| 0.111 | 0.041 | 0.111 | Glutamate (mGluR7) agonist | |||
| 0.087 | 0.017 | 0.101 | Cyclin B1 inhibitor | 0.101 0.011 CHEMBL210635 | CHEMBL210635 | |
| 0.097 | 0.027 | 0.412 | HIV-1 integrase (3'-Processing) inhibitor | 0.171 0.012 CHEMBL210635 0.412 0.004 CHEMBL3526944 0.325 0.005 CHEMBL3526945 | CHEMBL3526944 | |
| 0.094 | 0.024 | 0.117 | Leukotriene antagonist | 0.117 0.016 CHEMBL210635 0.104 0.02 CHEMBL3526944 0.077 0.034 CHEMBL3526945 | CHEMBL210635 | |
| 0.104 | 0.036 | 0.104 | Glutamate release inhibitor | |||
| 0.11 | 0.042 | 0.147 | Antineoplastic antibiotic | 0.147 0.031 CHEMBL210635 0.136 0.034 CHEMBL3526944 0.116 0.04 CHEMBL3526945 | CHEMBL210635 | |
| 0.217 | 0.151 | 0.341 | Cholesterol antagonist | 0.245 0.129 CHEMBL210635 0.341 0.068 CHEMBL3526944 0.339 0.069 CHEMBL3526945 | CHEMBL3526944 | |
| 0.08 | 0.015 | 0.098 | Cyclin B2 inhibitor | 0.098 0.009 CHEMBL210635 | CHEMBL210635 | |
| 0.094 | 0.029 | 0.094 | Phosphodiesterase 5A inhibitor | |||
| 0.094 | 0.032 | 0.094 | T cell inhibitor | 0.086 0.047 CHEMBL210635 | ||
| 0.088 | 0.027 | 0.374 | HIV-1 integrase (Strand Transfer) inhibitor | 0.162 0.012 CHEMBL210635 0.374 0.004 CHEMBL3526944 0.35 0.004 CHEMBL3526945 | CHEMBL3526944 | |
| 0.134 | 0.074 | 0.134 | Toll-Like receptor 9 antagonist | |||
| 0.248 | 0.188 | 0.248 | Transcription factor inhibitor | 0.243 0.192 CHEMBL210635 | ||
| 0.082 | 0.022 | 0.414 | Estrogen agonist | 0.273 0.005 CHEMBL210635 0.414 0.004 CHEMBL3526944 0.382 0.004 CHEMBL3526945 | CHEMBL3526944 | |
| 0.08 | 0.021 | 0.08 | GABA receptor antagonist | 0.067 0.027 CHEMBL210635 0.051 0.043 CHEMBL3526944 0.052 0.042 CHEMBL3526945 | ||
| 0.076 | 0.018 | 0.107 | Carbonic anhydrase XIV inhibitor | 0.107 0.009 CHEMBL210635 0.067 0.021 CHEMBL3526944 0.047 0.036 CHEMBL3526945 | CHEMBL210635 | |
| 0.091 | 0.033 | 0.117 | Lipase inhibitor | 0.117 0.019 CHEMBL210635 | CHEMBL210635 | |
| 0.121 | 0.064 | 0.13 | Proteasome inhibitor | 0.13 0.058 CHEMBL210635 | CHEMBL210635 | |
| 0.135 | 0.082 | 0.142 | CDC-like kinase 1 inhibitor | 0.142 0.076 CHEMBL210635 | CHEMBL210635 | |
| 0.079 | 0.026 | 0.171 | Neuraminidase (influenza) inhibitor | 0.115 0.013 CHEMBL210635 0.171 0.005 CHEMBL3526944 0.155 0.007 CHEMBL3526945 | CHEMBL3526944 | |
| 0.103 | 0.05 | 0.133 | Interleukin 12 antagonist | 0.133 0.019 CHEMBL210635 | CHEMBL210635 | |
| 0.069 | 0.017 | 0.109 | Topoisomerase II beta inhibitor | 0.109 0.008 CHEMBL210635 | CHEMBL210635 | |
| 0.094 | 0.043 | 0.094 | Inducible nitric-oxide synthase inhibitor | 0.081 0.06 CHEMBL210635 0.088 0.05 CHEMBL3526944 0.077 0.068 CHEMBL3526945 | ||
| 0.085 | 0.035 | 0.108 | Leukotriene synthesis inhibitor | 0.108 0.022 CHEMBL210635 | CHEMBL210635 | |
| 0.137 | 0.087 | 0.154 | Adenylate cyclase stimulant | 0.154 0.056 CHEMBL210635 0.147 0.069 CHEMBL3526944 0.142 0.078 CHEMBL3526945 | CHEMBL210635 | |
| 0.07 | 0.021 | 0.086 | Cyclin B inhibitor | 0.086 0.013 CHEMBL210635 | CHEMBL210635 | |
| 0.076 | 0.027 | 0.081 | Beta 3 adrenoreceptor antagonist | 0.081 0.022 CHEMBL210635 | CHEMBL210635 | |
| 0.072 | 0.024 | 0.072 | Calcium channel P-type blocker | |||
| 0.06 | 0.012 | 0.062 | Neuraminidase (Influenza A) inhibitor | 0.062 0.011 CHEMBL210635 | CHEMBL210635 | |
| 0.096 | 0.049 | 0.096 | Phosphodiesterase I inhibitor | |||
| 0.096 | 0.049 | 0.102 | NADH dehydrogenase inhibitor | 0.102 0.042 CHEMBL210635 | CHEMBL210635 | |
| 0.1 | 0.055 | 0.149 | Potassium channel (Ca-activated) activator | 0.149 0.028 CHEMBL210635 | CHEMBL210635 | |
| 0.076 | 0.032 | 0.097 | CDC25B inhibitor | 0.097 0.017 CHEMBL210635 | CHEMBL210635 | |
| 0.074 | 0.03 | 0.121 | Neuraminidase inhibitor | 0.101 0.015 CHEMBL210635 0.121 0.009 CHEMBL3526944 0.109 0.012 CHEMBL3526945 | CHEMBL3526944 | |
| 0.056 | 0.012 | 0.056 | Inosine monophosphate dehydrogenase inhibitor | 0.052 0.014 CHEMBL210635 | ||
| 0.09 | 0.048 | 0.104 | Glutathione S-transferase inhibitor | 0.104 0.034 CHEMBL210635 | CHEMBL210635 | |
| 0.128 | 0.087 | 0.169 | Farnesoid X receptor antagonist | 0.169 0.035 CHEMBL210635 | CHEMBL210635 | |
| 0.118 | 0.079 | 0.118 | Alpha-N-acetylglucosaminidase inhibitor | 0.118 0.079 CHEMBL210635 | ||
| 0.056 | 0.017 | 0.056 | Benzodiazepine antagonist | |||
| 0.101 | 0.063 | 0.104 | Bronchodilator | 0.104 0.06 CHEMBL210635 | CHEMBL210635 | |
| 0.26 | 0.222 | 0.26 | MAP kinase 1 inhibitor | |||
| 0.045 | 0.007 | 0.077 | Estrogen-related receptor beta antagonist | 0.077 0.003 CHEMBL210635 0.035 0.017 CHEMBL3526944 | CHEMBL210635 | |
| 0.069 | 0.032 | 0.069 | Phosphodiesterase 1C inhibitor | |||
| 0.1 | 0.063 | 0.141 | Anabolic | 0.124 0.035 CHEMBL210635 0.141 0.023 CHEMBL3526944 0.131 0.03 CHEMBL3526945 | CHEMBL3526944 | |
| 0.062 | 0.025 | 0.063 | Leukotriene C antagonist | 0.063 0.023 CHEMBL210635 | CHEMBL210635 | |
| 0.085 | 0.049 | 0.085 | Phosphodiesterase 3A inhibitor | |||
| 0.105 | 0.069 | 0.137 | DNA intercalator | 0.114 0.062 CHEMBL210635 0.092 0.082 CHEMBL3526944 0.137 0.048 CHEMBL3526945 | CHEMBL3526945 | |
| 0.047 | 0.011 | 0.047 | Vanilloid 3 antagonist | 0.039 0.024 CHEMBL210635 | ||
| 0.096 | 0.061 | 0.097 | Phosphodiesterase 6D inhibitor | 0.097 0.059 CHEMBL210635 | CHEMBL210635 | |
| 0.061 | 0.027 | 0.111 | Leukotriene B4 antagonist | 0.081 0.015 CHEMBL210635 0.111 0.008 CHEMBL3526944 0.071 0.019 CHEMBL3526945 | CHEMBL3526944 | |
| 0.12 | 0.088 | 0.132 | Vanilloid 1 agonist | 0.132 0.062 CHEMBL210635 0.115 0.1 CHEMBL3526944 0.117 0.096 CHEMBL3526945 | CHEMBL210635 | |
| 0.041 | 0.009 | 0.042 | Dopamine autoreceptor agonist | 0.042 0.009 CHEMBL210635 | CHEMBL210635 | |
| 0.058 | 0.026 | 0.069 | Glucose-6-phosphate translocase inhibitor | 0.069 0.016 CHEMBL210635 | CHEMBL210635 | |
| 0.078 | 0.046 | 0.078 | Adenosine A3 receptor antagonist | 0.076 0.049 CHEMBL210635 | ||
| 0.074 | 0.043 | 0.074 | Secretase beta inhibitor | |||
| 0.053 | 0.022 | 0.249 | Leukocyte elastase inhibitor | 0.202 0.004 CHEMBL3526944 0.249 0.004 CHEMBL3526945 | CHEMBL3526945 | |
| 0.084 | 0.054 | 0.103 | Estrogen-related receptor beta agonist | 0.103 0.021 CHEMBL210635 | CHEMBL210635 | |
| 0.077 | 0.047 | 0.109 | Glutamate decarboxylase inhibitor | 0.109 0.025 CHEMBL210635 | CHEMBL210635 | |
| 0.043 | 0.013 | 0.043 | ATM kinase inhibitor | |||
| 0.091 | 0.064 | 0.12 | HIV-1 integrase (Overall Integration) inhibitor | 0.12 0.04 CHEMBL210635 | CHEMBL210635 | |
| 0.084 | 0.058 | 0.084 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.07 | 0.044 | 0.07 | Acetylcholine M5 receptor agonist | |||
| 0.115 | 0.089 | 0.14 | Glycogen synthase kinase-3 alpha inhibitor | 0.14 0.073 CHEMBL210635 | CHEMBL210635 | |
| 0.04 | 0.014 | 0.04 | Melatonin receptor 1A agonist | |||
| 0.113 | 0.088 | 0.113 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.04 | 0.015 | 0.066 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.066 0.007 CHEMBL210635 | CHEMBL210635 | |
| 0.068 | 0.043 | 0.068 | Glutamate (mGluR6) antagonist | 0.064 0.055 CHEMBL210635 | ||
| 0.058 | 0.033 | 0.135 | Carbonic anhydrase XII inhibitor | 0.071 0.029 CHEMBL210635 0.135 0.014 CHEMBL3526944 0.078 0.026 CHEMBL3526945 | CHEMBL3526944 | |
| 0.058 | 0.033 | 0.058 | GABA A receptor antagonist | 0.048 0.044 CHEMBL210635 | ||
| 0.039 | 0.014 | 0.075 | ATP citrate lysase inhibitor | 0.075 0.004 CHEMBL210635 | CHEMBL210635 | |
| 0.093 | 0.069 | 0.1 | UDP-glucose 4-epimerase inhibitor | 0.1 0.061 CHEMBL210635 | CHEMBL210635 | |
| 0.099 | 0.076 | 0.099 | Alpha 2b adrenoreceptor antagonist | |||
| 0.055 | 0.032 | 0.081 | Heparanase inhibitor | 0.05 0.045 CHEMBL210635 0.076 0.008 CHEMBL3526944 0.081 0.006 CHEMBL3526945 | CHEMBL3526945 | |
| 0.033 | 0.01 | 0.122 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.122 0.004 CHEMBL210635 0.025 0.014 CHEMBL3526944 | CHEMBL210635 | |
| 0.064 | 0.041 | 0.064 | Nitric oxide donor | 0.058 0.052 CHEMBL210635 | ||
| 0.09 | 0.067 | 0.145 | Prolactin inhibitor | 0.145 0.024 CHEMBL210635 | CHEMBL210635 | |
| 0.071 | 0.048 | 0.071 | Peroxisome proliferator-activated receptor gamma agonist | 0.064 0.054 CHEMBL210635 | ||
| 0.065 | 0.043 | 0.066 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.05 CHEMBL210635 0.059 0.055 CHEMBL3526944 0.066 0.042 CHEMBL3526945 | CHEMBL3526945 | |
| 0.029 | 0.008 | 0.03 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.03 0.008 CHEMBL210635 | CHEMBL210635 | |
| 0.089 | 0.068 | 0.093 | ABCA1 expression enhancer | 0.093 0.06 CHEMBL210635 | CHEMBL210635 | |
| 0.037 | 0.016 | 0.048 | Protein kinase (CK2) beta inhibitor | 0.048 0.008 CHEMBL210635 | CHEMBL210635 | |
| 0.038 | 0.018 | 0.038 | Melatonin 2 agonist | 0.03 0.027 CHEMBL210635 | ||
| 0.041 | 0.022 | 0.052 | Arginase inhibitor | 0.052 0.014 CHEMBL210635 | CHEMBL210635 | |
| 0.056 | 0.037 | 0.113 | Maillard reaction inhibitor | 0.113 0.012 CHEMBL210635 | CHEMBL210635 | |
| 0.056 | 0.039 | 0.106 | Alcohol oxidase inhibitor | 0.106 0.017 CHEMBL210635 | CHEMBL210635 | |
| 0.117 | 0.1 | 0.117 | Activin receptor-like kinase 2 inhibitor | |||
| 0.047 | 0.03 | 0.047 | Adenylate cyclase 1 inhibitor | 0.044 0.034 CHEMBL210635 | ||
| 0.073 | 0.057 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.089 0.041 CHEMBL210635 0.098 0.033 CHEMBL3526944 0.096 0.036 CHEMBL3526945 | CHEMBL3526944 | |
| 0.067 | 0.051 | 0.067 | Exportin-1 inhibitor | |||
| 0.064 | 0.048 | 0.067 | Beta adrenoreceptor antagonist | 0.067 0.042 CHEMBL210635 | CHEMBL210635 | |
| 0.096 | 0.081 | 0.096 | 5 Hydroxytryptamine 3A agonist | |||
| 0.018 | 0.004 | 0.018 | Melatonin 2 antagonist | |||
| 0.035 | 0.021 | 0.035 | Melatonin 1 agonist | |||
| 0.039 | 0.026 | 0.04 | Leukotriene C4 antagonist | 0.04 0.025 CHEMBL210635 | CHEMBL210635 | |
| 0.043 | 0.03 | 0.043 | Heme oxygenase inhibitor | |||
| 0.139 | 0.126 | 0.139 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.083 | 0.071 | 0.217 | Triose-phosphate isomerase inhibitor | 0.217 0.009 CHEMBL3526944 0.203 0.01 CHEMBL3526945 | CHEMBL3526944 | |
| 0.042 | 0.03 | 0.042 | Guanylate cyclase inhibitor | |||
| 0.147 | 0.136 | 0.147 | Focal adhesion kinase 2 inhibitor | |||
| 0.018 | 0.006 | 0.018 | Melatonin receptor 1A antagonist | |||
| 0.033 | 0.022 | 0.033 | Melatonin agonist | |||
| 0.039 | 0.028 | 0.061 | Dopamine D5 agonist | 0.061 0.011 CHEMBL210635 | CHEMBL210635 | |
| 0.066 | 0.055 | 0.153 | HIV-1 integrase inhibitor | 0.112 0.019 CHEMBL210635 0.153 0.008 CHEMBL3526944 0.121 0.015 CHEMBL3526945 | CHEMBL3526944 | |
| 0.035 | 0.025 | 0.035 | Progesterone antagonist | |||
| 0.038 | 0.029 | 0.038 | Retinoic acid alpha receptor agonist | 0.036 0.033 CHEMBL210635 | ||
| 0.02 | 0.011 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.007 CHEMBL210635 | CHEMBL210635 | |
| 0.088 | 0.08 | 0.099 | Bile acid receptor antagonist | 0.097 0.056 CHEMBL210635 0.099 0.051 CHEMBL3526944 0.098 0.053 CHEMBL3526945 | CHEMBL3526944 | |
| 0.052 | 0.044 | 0.055 | Dihydroorotate oxidase inhibitor | 0.055 0.039 CHEMBL210635 | CHEMBL210635 | |
| 0.076 | 0.068 | 0.076 | Phosphodiesterase 11A inhibitor | |||
| 0.076 | 0.068 | 0.076 | Phosphodiesterase XI inhibitor | |||
| 0.162 | 0.156 | 0.162 | Interleukin agonist | |||
| 0.054 | 0.048 | 0.054 | Pregnane X receptor antagonist | 0.054 0.048 CHEMBL210635 | ||
| 0.091 | 0.086 | 0.123 | Toll-Like receptor 4 antagonist | 0.123 0.041 CHEMBL210635 | CHEMBL210635 | |
| 0.066 | 0.061 | 0.07 | MAP3K7 inhibitor | 0.07 0.054 CHEMBL210635 | CHEMBL210635 | |
| 0.042 | 0.036 | 0.042 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.138 | 0.133 | 0.185 | Phospholipase C inhibitor | 0.165 0.08 CHEMBL210635 0.185 0.056 CHEMBL3526944 0.18 0.061 CHEMBL3526945 | CHEMBL3526944 | |
| 0.021 | 0.016 | 0.168 | Estrone sulfatase inhibitor | 0.024 0.013 CHEMBL210635 0.168 0.003 CHEMBL3526944 0.139 0.004 CHEMBL3526945 | CHEMBL3526944 | |
| 0.087 | 0.082 | 0.087 | GABA C receptor agonist | 0.086 0.085 CHEMBL210635 | ||
| 0.025 | 0.021 | 0.03 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 CHEMBL210635 | CHEMBL210635 | |
| 0.072 | 0.067 | 0.072 | Interferon agonist | |||
| 0.171 | 0.167 | 0.218 | DNA synthesis inhibitor | 0.218 0.097 CHEMBL210635 | CHEMBL210635 | |
| 0.08 | 0.077 | 0.113 | Aminoacyl-tRNA synthetase inhibitor | 0.113 0.034 CHEMBL210635 0.083 0.072 CHEMBL3526944 | CHEMBL210635 | |
| 0.019 | 0.016 | 0.019 | Imidazoline I1 receptor antagonist | |||
| 0.154 | 0.151 | 0.317 | Immunostimulant | 0.222 0.108 CHEMBL210635 0.317 0.074 CHEMBL3526944 0.28 0.085 CHEMBL3526945 | CHEMBL3526944 | |
| 0.139 | 0.136 | 0.168 | Catenin beta inhibitor | 0.168 0.07 CHEMBL210635 | CHEMBL210635 | |
| 0.04 | 0.038 | 0.04 | Glutamate (mGluR group III) antagonist | |||
| 0.03 | 0.028 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.029 | 0.027 | 0.046 | Estrogen-related receptor alpha antagonist | 0.046 0.015 CHEMBL210635 | CHEMBL210635 | |
| 0.081 | 0.079 | 0.081 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.042 | 0.04 | 0.042 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.049 | 0.047 | 0.064 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.064 0.029 CHEMBL210635 | CHEMBL210635 | |
| 0.079 | 0.078 | 0.079 | Bromodomain-containing protein 2 inhibitor | |||
| 0.026 | 0.025 | 0.026 | Hedgehog signaling activator | |||
| 0.045 | 0.044 | 0.045 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.038 | 0.038 | 0.044 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.044 0.023 CHEMBL210635 | CHEMBL210635 | |
| 0.045 | 0.046 | 0.05 | Squalene epoxidase inhibitor | 0.05 0.035 CHEMBL210635 | CHEMBL210635 | |
| 0.027 | 0.029 | 0.127 | Estrogen receptor alpha agonist | 0.127 0.006 CHEMBL210635 0.05 0.017 CHEMBL3526944 0.035 0.023 CHEMBL3526945 | CHEMBL210635 | |
| 0.023 | 0.026 | 0.198 | Estrogen receptor beta agonist | 0.173 0.005 CHEMBL210635 0.198 0.005 CHEMBL3526944 0.18 0.005 CHEMBL3526945 | CHEMBL3526944 | |
| 0.052 | 0.057 | 0.062 | Purinergic P2X1 antagonist | 0.062 0.041 CHEMBL210635 | CHEMBL210635 | |
| 0.023 | 0.028 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.018 CHEMBL210635 | CHEMBL210635 | |
| 0.053 | 0.059 | 0.081 | Dopamine D1 antagonist | 0.081 0.032 CHEMBL210635 | CHEMBL210635 | |
| 0.05 | 0.062 | 0.085 | Sphingosine kinase inhibitor | 0.059 0.04 CHEMBL210635 0.085 0.013 CHEMBL3526944 0.068 0.027 CHEMBL3526945 | CHEMBL3526944 | |
| 0.036 | 0.049 | 0.055 | DNA gyrase subunit A inhibitor | 0.055 0.013 CHEMBL210635 | CHEMBL210635 | |
| 0.067 | 0.08 | 0.079 | GABA B receptor agonist | 0.079 0.043 CHEMBL210635 | CHEMBL210635 | |
| 0.062 | 0.075 | 0.066 | Glycine receptor agonist | 0.066 0.063 CHEMBL210635 | CHEMBL210635 | |
| 0.016 | 0.03 | 0.035 | Glutamate (mGluR1a) agonist | 0.023 0.014 CHEMBL3526944 0.035 0.007 CHEMBL3526945 | CHEMBL3526945 | |
| 0.024 | 0.04 | 0.094 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.094 0.005 CHEMBL210635 0.038 0.023 CHEMBL3526944 | CHEMBL210635 | |
| 0.055 | 0.072 | 0.091 | Potassium channel large-conductance Ca-activated activator | 0.091 0.028 CHEMBL210635 | CHEMBL210635 | |
| 0.047 | 0.063 | 0.06 | Androgen agonist | 0.06 0.041 CHEMBL210635 | CHEMBL210635 | |
| 0.045 | 0.063 | 0.184 | Carbonic anhydrase inhibitor | 0.184 0.011 CHEMBL3526944 0.134 0.019 CHEMBL3526945 | CHEMBL3526944 | |
| 0.05 | 0.074 | 0.071 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.071 0.027 CHEMBL210635 | CHEMBL210635 | |
| 0.048 | 0.072 | 0.086 | Heat shock protein 90 beta antagonist | 0.086 0.017 CHEMBL210635 | CHEMBL210635 | |
| 0.07 | 0.099 | 0.08 | Ca(v)3.1 blocker | 0.08 0.059 CHEMBL210635 | CHEMBL210635 | |
| 0.028 | 0.063 | 0.05 | Carbonic anhydrase IX inhibitor | 0.05 0.043 CHEMBL3526944 | CHEMBL3526944 | |
| 0.116 | 0.156 | 0.139 | Anesthetic general | 0.139 0.127 CHEMBL210635 | CHEMBL210635 | |
| 0.037 | 0.076 | 0.071 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.071 0.021 CHEMBL210635 0.049 0.044 CHEMBL3526944 | CHEMBL210635 | |
| 0.099 | 0.139 | 0.277 | Cell wall synthesis inhibitor | 0.144 0.071 CHEMBL210635 0.277 0.012 CHEMBL3526944 0.235 0.019 CHEMBL3526945 | CHEMBL3526944 | |
| 0.012 | 0.053 | 0.023 | Kynurenine 3 monooxygenase inhibitor | 0.023 0.022 CHEMBL3526945 | CHEMBL3526945 | |
| 0.065 | 0.107 | 0.085 | MAP kinase kinase 7 inhibitor | 0.085 0.034 CHEMBL210635 | CHEMBL210635 | |
| 0.173 | 0.228 | 0.264 | Sodium/bile acid cotransporter inhibitor | 0.264 0.113 CHEMBL210635 0.244 0.135 CHEMBL3526944 | CHEMBL210635 | |
| 0.025 | 0.082 | 0.055 | Carbonic anhydrase II inhibitor | 0.055 0.039 CHEMBL3526944 | CHEMBL3526944 | |
| 0.032 | 0.092 | 0.12 | Elastase inhibitor | 0.108 0.008 CHEMBL3526944 0.12 0.006 CHEMBL3526945 | CHEMBL3526945 | |
| 0.033 | 0.099 | 0.056 | CXC chemokine 1 receptor antagonist | 0.056 0.028 CHEMBL210635 | CHEMBL210635 | |
| 0.034 | 0.106 | 0.064 | Dopamine agonist | 0.064 0.049 CHEMBL3526944 | CHEMBL3526944 | |
| 0.09 | 0.163 | 0.372 | Diuretic | 0.372 0.015 CHEMBL3526944 0.327 0.019 CHEMBL3526945 | CHEMBL3526944 | |
| 0.021 | 0.095 | 0.052 | Carbonic anhydrase I inhibitor | 0.052 0.041 CHEMBL3526944 | CHEMBL3526944 | |
| 0.014 | 0.089 | 0.027 | Thyroid hormone agonist | 0.027 0.016 CHEMBL3526944 | CHEMBL3526944 | |
| 0.067 | 0.142 | 0.147 | DNA polymerase I inhibitor | 0.147 0.051 CHEMBL210635 | CHEMBL210635 | |
| 0.015 | 0.091 | 0.032 | Catechol O-methyltransferase inhibitor | 0.032 0.023 CHEMBL210635 | CHEMBL210635 | |
| 0.134 | 0.216 | 0.188 | MAP-kinase-activated kinase 5 inhibitor | 0.188 0.119 CHEMBL210635 | CHEMBL210635 | |
| 0.01 | 0.097 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.012 CHEMBL210635 | CHEMBL210635 | |
| 0.11 | 0.204 | 0.17 | Platelet antagonist | 0.155 0.139 CHEMBL3526944 0.17 0.126 CHEMBL3526945 | CHEMBL3526945 | |
| 0.143 | 0.265 | 0.226 | Immunosuppressant | 0.226 0.17 CHEMBL210635 | CHEMBL210635 | |
| 0.038 | 0.184 | 0.083 | Glycine receptor antagonist | 0.083 0.052 CHEMBL3526944 0.08 0.057 CHEMBL3526945 | CHEMBL3526944 | |
| 0.008 | 0.198 | 0.086 | Dopamine D2 agonist | 0.086 0.013 CHEMBL3526944 0.054 0.024 CHEMBL3526945 | CHEMBL3526944 | |
| 0.006 | 0.22 | 0.026 | Dopamine D1 agonist | 0.026 0.012 CHEMBL3526944 0.021 0.019 CHEMBL3526945 | CHEMBL3526944 | |
| 0.016 | 0.233 | 0.197 | Selectin antagonist | 0.185 0.013 CHEMBL3526944 0.197 0.011 CHEMBL3526945 | CHEMBL3526945 | |
| 0.014 | 0.241 | 0.033 | Toll-Like receptor 4 agonist | 0.03 0.011 CHEMBL3526944 0.033 0.008 CHEMBL3526945 | CHEMBL3526945 | |
| 0.04 | 0.277 | 0.207 | Thrombolytic | 0.207 0.049 CHEMBL3526944 0.178 0.063 CHEMBL3526945 | CHEMBL3526944 | |
| 0.007 | 0.261 | 0.042 | Factor Xa inhibitor | 0.042 0.035 CHEMBL3526945 | CHEMBL3526945 | |
| 0.005 | 0.262 | 0.74 | Cholecystokinin A agonist | 0.726 0.002 CHEMBL3526944 0.74 0.001 CHEMBL3526945 | CHEMBL3526945 | |
| 0.004 | 0.335 | 0.758 | Cholecystokinin agonist | 0.748 0.002 CHEMBL3526944 0.758 0.002 CHEMBL3526945 | CHEMBL3526945 | |
| 0.011 | 0.413 | 0.056 | H+/K+-transporting ATPase inhibitor | 0.056 0.029 CHEMBL3526945 | CHEMBL3526945 | |
| 0.01 | 0.474 | 0.046 | Purinergic P2Y2 antagonist | 0.046 0.012 CHEMBL3526944 0.039 0.016 CHEMBL3526945 | CHEMBL3526944 | |
| 0.006 | 0.48 | 0.081 | NMDA 2D receptor antagonist | 0.07 0.005 CHEMBL3526944 0.081 0.004 CHEMBL3526945 | CHEMBL3526945 | |
| 0.004 | 0.481 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.037 0.005 CHEMBL3526944 0.037 0.005 CHEMBL3526945 | CHEMBL3526945 | |
| 0.022 | 0.512 | 0.079 | Adenine nucleotide translocase inhibitor | 0.079 0.009 CHEMBL3526944 0.073 0.013 CHEMBL3526945 | CHEMBL3526944 | |
| 0.004 | 0.641 | 0.236 | NMDA 2B receptor antagonist | 0.22 0.005 CHEMBL3526944 0.236 0.005 CHEMBL3526945 | CHEMBL3526945 | |
| 0.008 | 0.661 | 0.082 | Thrombin inhibitor | 0.082 0.04 CHEMBL3526944 0.073 0.05 CHEMBL3526945 | CHEMBL3526944 | |
| 0.013 | 0.697 | 0.077 | Factor IXa inhibitor | 0.07 0.02 CHEMBL3526944 0.077 0.017 CHEMBL3526945 | CHEMBL3526945 | |
| 0.007 | 0.781 | 0.473 | Anticoagulant | 0.397 0.017 CHEMBL3526944 0.473 0.012 CHEMBL3526945 | CHEMBL3526945 | |
| 0.002 | 0.872 | 0.297 | Cholecystokinin A antagonist | 0.294 0.004 CHEMBL3526944 0.297 0.004 CHEMBL3526945 | CHEMBL3526945 | |
| 0.002 | 0.919 | 0.215 | Cholecystokinin antagonist | 0.21 0.004 CHEMBL3526944 0.215 0.004 CHEMBL3526945 | CHEMBL3526945 | |
| 0.005 | 0.944 | 0.674 | Cholecystokinin B agonist | 0.669 0.001 CHEMBL3526944 0.674 0.001 CHEMBL3526945 | CHEMBL3526945 | |
| 0.002 | 0.955 | 0.187 | Cholecystokinin B antagonist | 0.183 0.004 CHEMBL3526944 0.187 0.004 CHEMBL3526945 | CHEMBL3526945 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |